The Recall Desk

FDA (Drugs) recall action 89871

Dr. Reddy's Laboratories, Inc. recalled 2 products on 2022-04-06

The FDA (Drugs) publishes a recall like this one as 2 separate product records. They share a firm, a date and a cause; this page is all of them in one place, so the scale of the action is visible rather than spread across 2 pages.

Products
2
Announced
2022-04-06
Critical
0
Units
7,703

Why these products were recalled

Failed Dissolution Specifications; during long term stability testing.

The agency’s own wording, quoted from the enforcement report.

The unit total adds up the quantities the agency stated for each product. Where a product record gave no figure, or gave a weight rather than a count, it contributes nothing — so the real total is at least this, never less.

1–2 of 2

  • HighFDA (Drugs)··2022-04-06

    Lansoprazole Capsules Recalled for Failed Dissolution in Stability Testing

    Dr. Reddy's Laboratories is recalling specific lots of Lansoprazole 15 mg delayed-release capsules nationwide because the capsules failed to dissolve properly during long-term stability testing, which could affect medication effectiveness.

    Product
    LANSOPRAZOLE (LANSOPRAZOLE)
    Category
    Distribution
    0 states